GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

Overview

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is the #17 most commonly reported adverse reaction for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, manufactured by RB Health (US) LLC. There are 177 FDA adverse event reports linking GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE to WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. This represents approximately 1.3% of all 13,133 adverse event reports for this drug.

Patients taking GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE who experience wrong technique in product usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is a less commonly reported adverse event for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, but still significant enough to appear in the safety profile.

Other Side Effects of GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE

In addition to wrong technique in product usage process, the following adverse reactions have been reported for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE:

• DRUG INEFFECTIVE — 921 reports
• DIZZINESS — 833 reports
• DIARRHOEA — 621 reports
• ACCIDENTAL OVERDOSE — 524 reports
• NAUSEA — 501 reports
• OVERDOSE — 381 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 345 reports
• SOMNOLENCE — 292 reports
• FEELING ABNORMAL — 283 reports
• VOMITING — 279 reports

Other Drugs Associated with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

The following drugs have also been linked to wrong technique in product usage process in FDA adverse event reports:

Does GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE cause WRONG TECHNIQUE IN PRODUCT USAGE PROCESS?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS has been reported as an adverse event in 177 FDA reports for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN PRODUCT USAGE PROCESS with GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS accounts for approximately 1.3% of all adverse event reports for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, making it a notable side effect.

What should I do if I experience WRONG TECHNIQUE IN PRODUCT USAGE PROCESS while taking GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?

If you experience wrong technique in product usage process while taking GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages